Cardiac Medications

Cardiovascular Medication Foundations and Patient Education

  • Rationale for Cardiovascular Medications: Patient may require these medications for several conditions, including:     - Hypertension (HTNHTN)     - Hypotension     - Congestive Heart Failure (CHFCHF)     - Dysrhythmias     - Angina     - Edema     - Hypercholesteremia

  • Antihypertensive Considerations and Lifestyle Modifications:     - Treatment must include lifestyle modifications focused on diet and physical activity.

  • Nursing Interventions and Education for Antihypertensives:     - Side Effects: Patients should be warned about potential impotence or Erectile Dysfunction (EDED).     - Assessments: Nurses must assess body weight, vital signs, and hydration status.     - Safety: Assess orthostatic blood pressures to prevent orthostatic hypotension.     - Lab Monitoring: Follow renal function profiles and coagulation labs.     - Administration: Medications should be taken at the same time every single day.     - Environmental Warnings: Avoid hot tubs and saunas because they cause vasodilation which can lead to fainting.     - Adherence: Do not discontinue medications abruptly.     - Reporting: Report all adverse effects to the provider immediately.

ACE Inhibitors (Angiotensin Converting Enzyme Inhibitors)

  • Nomenclature: These medications typically end in the suffix −pril-pril.

  • Examples: Lisinopril, enalapril, captopril, and fosinopril.

  • Mechanism of Action: Blocks Angiotensin II from converting into Angiotensin IIII, which is a potent vasoconstrictor.

  • Therapeutic Uses (TxTx): Hypertension (HTNHTN), Heart Failure (HFHF), Myocardial Infarction (MIMI), and diabetic neuropathy (to delay disease progression).

  • Precautions: Use caution with concurrent diuretic therapy; monitor potassium levels.

  • Adverse Effects:     - Persistent Non-protective Cough: Caused by bradykinin making the airway sensitive.     - Angioedema: Severe swelling of the deep layers of the skin.     - Pregnancy Warning: Never used in the 2nd2nd and 3rd3rd trimester of pregnancy due to risk of fetal injury.     - Mnemonic (ACE): Angioedema, Cough, Elevated potassium (hyperkalemia).

  • Nursing Interventions/Education:     - Captopril Specifics: Should be taken 1 hour1\,hour before meals. Potential for rash, dysgeusia (altered taste), and neutropenia (rare).     - Interactions: NSAIDS\text{NSAIDS} decrease the effectiveness of ACE\text{ACE} inhibitors. ACE\text{ACE} inhibitors increase the effectiveness/levels of Lithium.

ARBS (Angiotensin II Receptor Blockers)

  • Nomenclature: These medications typically end in the suffix −sartan-sartan.

  • Examples: Valsartan, losartan, and irbesartan.

  • Mechanism of Action: Selectively block the binding of Angiotensin IIII to AT1AT1 receptors in various tissues.

  • Precautions and Adverse Effects:     - Angioedema: If a patient experienced angioedema with ACE\text{ACE} inhibitors, use ARBS\text{ARBS} very cautiously, especially if there is a family history.     - Skeletal Muscle Damage: Can cause rhabdomyolysis (destruction of skeletal muscle).     - Renal Warning: Patients with narrowing arteries into the kidneys (renal artery stenosis) will have difficulty with ARBS\text{ARBS}.     - GI Upset: General gastrointestinal discomfort.

Direct Renin Inhibitors

  • Example: Aliskiren.

  • Mechanism of Action: Binds directly with renin to inhibit the production of Angiotensin II.

  • Adverse Effects: Angioedema, cough, and hyperkalemia.

  • Contraindications/Precautions:     - Not for use during pregnancy.     - Use cautiously in geriatric patients, those with renal disease, respiratory diseases, or asthma.

  • Interactions:     - Decreases furosemide levels.     - Atorvastatin increases aliskiren levels.     - High fat meals interfere with the absorption of the drug.

Loop Diuretics

  • Nomenclature: Often ends in the suffix −ide-ide.

  • Examples: Furosemide, torsemide, bumetanide, and ethacrynic acid.

  • Mechanism of Action: Work in the Loop of Henle to block the reabsorption of sodium and chloride, which prevents the reabsorption of water.

  • Therapeutic Uses (TxTx): Emergent need for rapid fluid movement, pulmonary edema from heart failure, or edema not responding to other diuretics caused by heart, liver, kidney disease, or HTNHTN.

  • Adverse Effects:     - Dehydration and electrolyte imbalances, specifically hypokalemia (low potassium).     - Hypotension.     - Ototoxicity: Hearing loss/damage.

  • Contraindications/Precautions:     - Contraindicated if the patient is anuric (no urine production).     - Cautious use with other ototoxic or nephrotoxic drugs.     - NSAIDS\text{NSAIDS} decrease blood flow to the kidneys.     - Use caution in patients with diabetes, cardiovascular disease, or those taking other antihypertensives.     - Digoxin Interaction: Hypokalemia increases the risk of digoxin toxicity.     - Lithium Interaction: Low sodium levels (hyponatremia) can lead to increased lithium levels and toxicity.     - Lactation: Can decrease milk production.

  • Nursing Implications/Education:     - Patients may suck on hard candy for dry mouth.     - Monitor electrolytes, kidney function, and urine output (maintain at least 30 mL/hr30\,mL/hr).     - Monitor daily weights (dwdw), blood pressure (bpbp), and lab values.     - Change positions slowly to avoid falls.     - Consume foods high in potassium.     - Diabetics should monitor glucose.     - IV Administration: IVIV push must be slow at a rate of 20 mg/min20\,mg/min. Use ECG\text{ECG} monitoring. Give during the day to avoid nocturia.

Thiazide Diuretics

  • Nomenclature: Ends in −thiazide-thiazide.

  • Examples: Hydrochlorothiazide (HCTZHCTZ), chlorothiazide, methyclothiazide, indapamide, chlorthalidone, and metolazone.

  • Mechanism of Action: Work in the beginning of the distal convoluted tubule to block absorption of sodium and chloride, preventing water reabsorption.

  • Therapeutic Uses (TxTx):     - First-line medication for essential HTNHTN.     - Edema for mild to moderate disease; often used in combination with other antihypertensives.     - Reduces urine production in diabetes insipidus.     - Promotes reabsorption of calcium, which can reduce the risk of postmenopausal osteoporosis.

  • Adverse Effects: Similar to loop diuretics. Pregnancy contraindication as it reduces nutrients to the fetus; harmful during breastfeeding.

  • Distinguishing Factor: No risk to hearing loss (ototoxicity\text{ototoxicity}); can be used safely with ototoxic medications.

  • Nursing Interventions: Similar to loop diuretics. Note that chlorothiazide is the only one capable of IVIV administration; all others are administered POPO.

Potassium-Sparing Diuretics

  • Examples: Spironolactone (an aldosterone antagonist), triamterene, and amiloride.

  • Mechanism of Action: Blocks aldosterone, which normally causes sodium and water retention. This results in potassium retention and the excretion of sodium and water.

  • Therapeutic Uses (TxTx): Takes 12−48 hours12-48\,hours to take effect. Used with other diuretics for their potassium-sparing effect in heart failure. Administered via POPO route.

  • Adverse Effects:     - Hyperkalemia and hyponatremia.     - Endocrine Changes: Gynecomastia (enlarged male breast tissue), impotence, deepening of the voice, and hirsutism (excessive/unexpected hair growth).

  • Precautions/Interactions:     - Caution with ACE\text{ACE} inhibitors as they also elevate potassium.     - Caution in severe kidney failure, anuric patients, or those in metabolic acidosis.

  • Nursing Implications/Education:     - If hyperkalemic, treat with IVIV potassium-excreting meds.     - No potassium supplements.     - Avoid salt substitutes as they contain potassium.     - Decrease intake of potassium-rich foods.     - Triamterene Note: Can turn urine a bluish color.     - Reporting: Report cramps, diarrhea, thirst, altered menstruation, or deepened voice.     - Monitor for lithium toxicity.

Osmotic Diuretics

  • Example: IVIV Mannitol.

  • Mechanism of Action: Reduces intracranial and intraocular pressure by raising serum osmolarity and shifting fluids back into the vascular and extravascular space.

  • Therapeutic Uses (TxTx):     - Kidney failure from hypovolemic shock or severe hypotension.     - Oliguria phase of Acute Kidney Injury (AKIAKI).     - Decrease Intracranial Pressure (ICPICP).     - Decrease intraocular pressure.     - Sodium retention for patients with hyponatremia or fluid volume excess.

  • Adverse Effects: Heart failure, pulmonary edema, fluid and electrolyte imbalances leading to metabolic acidosis, and rebound increase in ICPICP.

  • Contraindications/Interactions:     - Do not use with active intracranial bleeds or renal failure.     - Increases lithium levels.     - Avoid licorice if taking with antihypertensives (increased risk of hypokalemia).

  • Nursing Implications: Monitor daily weight, I&OI\&O, BMPBMP (Basic Metabolic Panel), signs of increased ICPICP, dehydration, blood pressure, and kidney function. Falls risk due to position changes.

Calcium Channel Blockers (CCBCCB)

  • Nomenclature: Ends in −zem-zem or −dipine-dipine.

  • Examples: Nifedipine, amlodipine, diltiazem, and verapamil.

  • Administration: Can be sustained or extended release; these must never be crushed or chewed.

  • Mechanism of Action: Slows the movement of calcium into smooth-muscle cells, causing arterial dilation and decreased blood pressure.

  • Therapeutic Uses (TxTx): Hypertension and Angina. Verapamil and diltiazem are specifically used for Atrial Fibrillation (a−fiba-fib), Atrial Flutter (a−fluttera-flutter), and Supraventricular Tachycardia (SVTSVT).

  • Precautions/Interactions:     - Caution with Digoxin and Beta Blockers.     - Contraindicated in heart failure, heart block, and bradycardia.     - Toxic Interaction: Toxic effects occur if taken with GRAPEFRUIT JUICE\text{GRAPEFRUIT JUICE}.

  • Adverse Effects: Constipation, reflex tachycardia, peripheral edema, acute toxicity, suppression of cardiac function, and dysrhythmias (widened QRSQRS, prolonged QTQT).

  • Nursing Interventions: IVIV push should be administered over 2−3 minutes2-3\,minutes. Taper the dose if discontinuing (d/cd/c).

Alpha Adrenergic Blockers

  • Nomenclature: Ends in −zosin-zosin.

  • Examples: Prazosin, terazosin, and doxazosin.

  • Mechanism of Action: Inhibit Alpha 11 adrenergic receptors, causing peripheral arterial and venous dilation to lower blood pressure.

  • Therapeutic Uses (TxTx): Primary hypertension; doxazosin is used for Benign Prostatic Hypertrophy (BPHBPH).

  • Precautions/Interactions: Increased risk of hypotension and syncope (fainting) when used with other antihypertensives, beta blockers, or diuretics. NSAIDS\text{NSAIDS} decrease the effects of prazosin.

  • Adverse Effects: Dizziness and fainting.

  • Nursing Interventions/Education: Take the medication at bedtime. Consult a medical doctor before taking any OTC\text{OTC} medications.

Alpha 2 Agonist

  • Examples: Clonidine, guanfacine, and methyldopa.

  • Mechanism of Action: Acts on Alpha 22 receptors in the brain to reduce peripheral vascular resistance, heart rate, and both systolic and diastolic blood pressure.

  • Therapeutic Uses (TxTx): Primary hypertension (with diuretics/antihypertensives), hypertensive crisis, severe cancer pain (via epidural), and ADHDADHD.

  • Precautions/Interactions:     - Contraindicated with anticoagulants and hepatic failure.     - Never take with MAOIs\text{MAOIs}.     - Methyldopa must never be in the same line as barbiturates or sulfonamides.     - Caution with CVACVA, Myocardial Infarction, diabetes, major depression, or chronic renal failure.     - Never use during lactation.

  • Adverse Effects: Dry mouth, drowsiness/sedation, rebound hypertension (48 hours48\,hours after discontinuation), black or sore tongue, and leukopenia.

  • Nursing Interventions/Education: Monitor for CNSCNS effects and routine CBCCBC labs. Never skip a dose. Take at bedtime (qhsqhs). Notify the doctor regarding involuntary jerking, prolonged dizziness, rash, or yellowing of the skin. Manage dry mouth with fluids or hard candy.

Beta Blockers

  • Nomenclature: Ends in −lol-lol.

  • Examples:     - Cardioselective: Metoprolol, atenolol, metoprolol succinate (erer).     - Nonselective: Propranolol, nadolol, labetalol, carvediolol.

  • Mechanism of Action: Inhibit stimulation of receptor sites to decrease cardiac excitability, cardiac output, and myocardial oxygen demand. Lowers blood pressure by decreasing renin release in the kidney.

  • Therapeutic Uses (TxTx): Primary hypertension, angina, tachydysrhythmias, Heart Failure (HFHF), and Myocardial Infarction (MIMI).

  • Precautions/Interactions:     - Contraindicated with AVAV block or bradycardia.     - Respiratory Warning: NEVER\text{NEVER} give nonselective beta blockers to patients with asthma, bronchospasms, or worsening heart failure.     - Diabetic Warning: Propranolol can mask signs of hypoglycemia.     - Labetalol must not be administered in the same line as furosemide.

  • Adverse Effects: Bradycardia, nasal stuffiness, AVAV block, bronchospasms, and rebound myocardium excitation if the drug is stopped abruptly.

  • Nursing Interventions: Hold the medication if systolic bp<100bp < 100 or HR<60HR < 60.

Vasodilators

  • Examples: Nitroglycerine, nitroprusside, hydralazine, and isosorbide.

  • Mechanism of Action: Vasodilates both arteries and veins for rapid reduction of blood pressure, decreasing both preload and afterload.

  • Therapeutic Uses (TxTx): Hypertensive crisis and chest pain.

  • Precautions/Interactions:     - Caution in hepatic/renal disease, elderly, or those with electrolyte imbalances.     - Contraindication: Never use with Erectile Dysfunction drugs like sildenafil.     - Contraindicated in head injuries and closed-angle glaucoma due to increased ICPICP.

  • Adverse Effects: Dizziness, headache (HAHA), hypotension. Nitroprusside only: Cyanide and thiocyanate poisoning.

  • Nursing Interventions for Nitroprusside: Never mix with any other medication. Use a protective cover to shield from light. Fluid is only stable for 24 hours24\,hours. Monitor ECG\text{ECG} and vitals.

Organic Nitrates (Antianginal)

  • Mechanism of Action: Relaxes peripheral vascular smooth muscle to dilate arteries and veins. Reduces preload/oxygen demand and increases oxygen supply by dilating coronary arteries.

  • Therapeutic Uses (TxTx): Acute angina and prophylaxis of chronic stable or variant angina.

  • Prophylaxis Protocol: Take 5−10 minutes5-10\,minutes before exercise.

  • Storage and Safety: Never shake the container. Keep in a dark container and replace every 6 months6\,months. Wear a medical alert bracelet.

  • Acute Chest Pain Protocol:     - Take 1 tablet1\,tablet at the onset of chest pain (CPCP).     - Repeat every 5 minutes5\,minutes if pain continues.     - MAX: 3 tablets3\,tablets.     - Call 911911 after the 1st1st tablet if pain is unrelieved.

  • Transdermal Nitro Patch Education:     - Wear gloves during application.     - Rotate sites on clean, dry, hairless skin.     - Remove at night to prevent tolerance.     - Wipe off old ointment before applying more.     - Label with initials, date, and time. Document placement.

Ranolazine (Antianginal)

  • Form: Prolonged release.

  • Mechanism of Action: Lowers cardiac oxygen demand and decreases sodium and calcium in myocardial cells.

  • Therapeutic Uses (TxTx): Chronic (long-term) stable chest pain used with other antihypertensives.

  • Precautions/Interactions:     - Grapefruit juice, macrolides, and antifungals increase ranolazine levels.     - Quinidine and sotalol prolong the QT\text{QT} interval.     - Increases levels of Digoxin and simvastatin.

  • Adverse Effects: Prolonged QTQT (risk of torsades) and hypertension.

  • Nursing Interventions: Monitor blood pressure and ECG\text{ECG}. Report chest pain or palpitations. Not for acute angina attacks. Do not crush or chew extended release (ERER). Establish a baseline digoxin level.

Cardiac Glycosides: Digoxin

  • Mechanism of Action: Used for heart failure or ineffective pumping; increases force/velocity of myocardial contractions (positive inotrope\text{positive inotrope}) to improve stroke volume and cardiac output. Slows conduction rate to increase ventricular filling (negative chronotrope\text{negative chronotrope}).

  • Therapeutic Uses (TxTx): Heart failure and Atrial Fibrillation (a−fiba-fib).

  • Precautions/Interactions:     - Thiazide or loop diuretics increase risk of hypokalemia and precipitate digoxin toxicity.     - ACE\text{ACE} inhibitors and ARBS\text{ARBS} also carry a risk of hyperkalemia/hypokalemia issues.     - Verapamil increases the risk of digoxin toxicity.

  • Nursing Interventions: Assess apical pulse for a full minute. Notify provider if HR<60HR < 60 for an adult, <70< 70 for a child, or <90< 90 for an infant. Monitor for toxicity, hypokalemia, and hypomagnesemia.

Digoxin Toxicity Management

  • Therapeutic Range: 0.8−2.0 ng/mL0.8-2.0\,ng/mL.

  • Gastrointestinal Symptoms: Anorexia, nausea, vomiting, and abdominal pain.

  • CNS Symptoms: Fatigue, weakness, diplopia (double vision), blurred vision, and yellow-green or white halos around objects.

  • Management Steps:     - Discontinue digoxin and any potassium-wasting medications.     - Treat dysrhythmias with phenytoin or lidocaine.     - Treat bradycardia with atropine.     - Antidote: Digoxin immune FAB to prevent further absorption.

Antidysrhythmic Classifications

  • Class 1 A: Procainamide - Slows impulses and delays repolarization.

  • Class 1 B: Lidocaine - Decreased electrical conduction and increased repolarization. Used exclusively for ventricular dysrhythmias. Adverse effects include lupus-like syndrome, leukopenia, thrombocytopenia, and arrhythmias.

  • Class 1 C: Propafenone, Flecainide - Decrease conduction velocity and delay ventricular repolarization; used for Supraventricular Tachycardia (SVTSVT).

  • Other Supportive Classes:     - Beta blockers: Prevent sympathetic nervous system stimulation of the heart.     - Calcium channel blockers: Prolong cardiac conduction, depress repolarization and oxygen demand.     - Digoxin: Decreases electrical conduction through the AVAV node and decreases automaticity in the SASA node; increases contraction.

Specific Antidysrhythmic Agents

  • Adenosine:     - Action: Slows conduction through AVAV node to restore Normal Sinus Rhythm (NSRNSR).     - Tx: Convert SVTSVT to Sinus Rhythm (SRSR).     - Adverse Effects: Flushing, nausea, bronchospam, and prolonged asystole.     - Nursing Interventions: Rapid IVIV push over 1−2 seconds1-2\,seconds (due to very short half-life). Flush immediately with normal saline (N/SN/S).

  • Amiodarone:     - Action: Prolongs repolarization and relaxes smooth muscle, decreasing vascular resistance.     - Tx: V-fib, unstable v-tach, a-fib.     - Adverse Effects: Bradycardia, cardiogenic shock, pulmonary toxicity, and liver toxicity.     - Nursing Interventions: Incompatible with heparin. May give oral maintenance dose. Monitor for respiratory complications. Use a filter line. It is a vesicant.

  • Atropine:     - Action: Increases heart rate by counteracting muscarine-like actions of acetylcholine.     - Tx: Bradycardia, exposure to chemical nerve agents, and reduction of secretions.     - Adverse Effects: No contraindications when using during Advanced Cardiovascular Life Support (ACLSACLS).     - Nursing Interventions: Monitor for dry mouth, blurred vision, photophobia, urinary retention, and constipation.

Adrenergic Agonists and Vasopressors

  • Agents: Epinephrine, dopamine, dobutamine, norepinephrine, isoproterenol, and ephedrine.

  • Mechanism by Receptor:     - Alpha 1: Vasoconstriction and pupil dilation.     - Beta 1 (Dobutamine): Heart stimulation (increased HRHR, contractility, conduction velocity), renin release, improved perfusion in Heart Failure.     - Beta 2 (Ephedrine): Bronchodilation, delaying preterm labor, and treating hypotension.     - Dopamine Receptors: Dilation of renal vessels to increase renal perfusion and reduce the risk of renal failure.

  • Specific Agent Applications:     - Epinephrine: Acts on Alpha, Beta 1, and Beta 2. Used for anaphylactic shock, slowing local anesthetic absorption, superficial bleeding, increasing bpbp, nasal congestion, AVAV block, Heart Failure, and asthma.     - Dopamine: Dose-dependent action. High doses cause vasoconstriction (Alpha). Lower doses dilate renal vessels. Used for shock and Acute Kidney Injury (AKIAKI).     - Dobutamine: Acts specifically on Beta 1 for Heart Failure.

Complications and Nursing Care for Agonists

  • Complications:     - Hypertensive crisis (risk of cerebral hemorrhage).     - Dysrhythmias due to increased workload and oxygen demand.     - Necrosis from extravasation (tissue death at IV\text{IV} site). If this occurs, administer phentolamine.

  • Contraindications/Precautions:     - Dopamine is contraindicated with tachydysrhythmias.     - Epinephrine caution with hyperthyroid, angina, and HTNHTN.     - Avoid MAOIs\text{MAOIs}. Lower doses if the patient is on tricyclic antidepressants.

  • Nursing Interventions:     - Cardiac and vital sign monitoring; report changes.     - Monitor urine output and chest pain (CPCP).     - IV Access: Use a central line if possible. Titrate dose based on blood pressure, capillary refill, Cardiac Output (COCO), pulmonary wedge pressure, central venous pressure (CVPCVP), and hyperglycemia.

Antilipemic Medications

  • General Goal: Lower LDLLDL (bad cholesterol) and increase HDLHDL (good cholesterol).

  • Concurrent Therapy: Must be used with diet, exercise, and weight control.

  • Therapeutic Uses (TxTx): Primary hypercholesterolemia, prevention of coronary events, and protection against Myocardial Infarction and stroke in diabetic patients.

  • Precautions: Discontinue during pregnancy. Caution with renal dysfunction.

  • Adverse Effects: Muscle aches, hepatotoxicity (liver damage), rhabdomyolysis (measured by CKCK levels), and peripheral neuropathy.

  • Nursing Education: Take in the evening because most cholesterol is synthesized overnight. Monitor liver and renal function (BUN, creatinine). Maintain a low-fat/high-fiber diet.

HMG COA Reductase Inhibitors (Statins)

  • Examples: Atorvastatin, simvastatin, lovastatin, pravastatin, rosuvastatin, and fluvastatin.

  • Mechanism: Interfere with the hepatic enzyme HMG COAHMG\,COA to reduce cholesterol formation.

  • Interactions: Prolonged bleeding with warfarin. Interactions with digoxin, thyroid hormones, thiazides, phenobarbital, NSAIDS\text{NSAIDS}, tetracycline, beta-blockers, gemfibrozil, glipizide, and oral contraceptives.

  • Nursing Warning: NEVER\text{NEVER} take with grapefruit juice.

Cholesterol Absorption Inhibitors and Bile-Acid Sequestrants

  • Ezetimibe (Cholesterol Absorption Inhibitor): Inhibits cholesterol absorption from bile and food. Take 2 hours2\,hours before or 4 hours4\,hours after other antilipemics. Risk of liver damage increases when combined with statins.

  • Bile-Acid Sequestrants: Colesevelam, cholestyramine, and colestipol.     - Contraindications: Bowel obstruction or pancreatitis.     - Interactions: Levothyroxine, phenytoin, fat-soluble vitamins, and digoxin. Take interacting meds 1 hour1\,hour before or 4 hours4\,hours after sequestrants.     - Adverse Effect: Constipation (manage with fluid, fiber, activity).     - Preparation: Dissolve powder in 4−8 oz4-8\,oz of fluid. Colesevelam should be taken with food or 8 oz8\,oz water. Colestipol should be taken 30 minutes30\,minutes before food.

Fibrates and Monoclonal Antibodies

  • Fibrates: Gemfibrozil and fenofibrate.     - Action: Decrease triglycerides and increase HDLHDL.     - Contraindications: Liver, kidney, and gallbladder disease.     - Adverse Effects: GI\text{GI} distress, gallstones, myopathy, and hepatotoxicity.     - Nursing Care: Monitor for RUQRUQ pain (Right Upper Quadrant), jaundice, and CKCK levels. Monitor PT/INRPT/INR for bleeding. Take 30 minutes30\,minutes prior to breakfast and dinner.

  • Monoclonal Antibodies: Alirocumab and evolocumab.     - Mechanism: Bind to LDLLDL receptors to decrease LDLLDL.     - Tx: Used after other meds and lifestyle modifications fail.     - Adverse Effects: Hypersensitivity and injection site reactions.     - Education: Monitor for rash, urticaria, pruritus, or vasculitis. Rotate subcutaneous (subqsub q) injection sites.